Search results
Tammy J. Clifford, Acting President (effective April 8, 2024) Past Presidents of the Canadian Institutes of Health Research.
- CIHR Strategic Plan 2021–2031
Michael J. Strong, MD, FRCPC, FAAN, FCAHS President, CIHR....
- CIHR Strategic Plan 2021–2031
- News release
- Quotes
Today, the Honourable Ginette Petitpas Taylor, Minister of Health, announced that Dr. Michael J. Strong has been appointed the new President of the Canadian Institutes of Health Research
June 20, 2018 – Ottawa, Ontario – Canadian Institutes of Health Research
Today, the Honourable Ginette Petitpas Taylor, Minister of Health, announced that Dr. Michael J. Strong has been appointed the new President of the Canadian Institutes of Health Research (CIHR). Dr. Strong is an internationally recognized researcher specializing in the neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. He will take up his position on October 1.
Dr. Strong’s research focuses on understanding the cellular biology of ALS. His work has helped shed new light on a process by which an abnormal form of some proteins may accumulate in nerve cells in the spinal cord and brain, destroying the cells, and leading to the symptoms of the disease.
Dr. Strong will bring extensive leadership experience to CIHR, having served since 2010 as the Dean of the Schulich School of Medicine & Dentistry and Distinguished University Professor at Western University, where he holds the Arthur J. Hudson Chair in ALS Research. From 2000 to 2010, he served as the Chief of Neurology and Co-Chair of the Department of Clinical Neurological Sciences at the London Health Sciences Centre and Western University.
Dr. Strong will replace Dr. Roderick McInnes, whose last day as Acting President of CIHR is June 30. Michel Perron, Executive Vice-President of CIHR, will lead the transition process until Dr. Strong’s arrival.
“I am pleased to announce the appointment of Dr. Michael Strong as the new President of CIHR. Dr. Strong’s distinguished track record as a biomedical researcher, professor, and administrator, whose contributions to science include expanding our understanding of the neurodegenerative disease amyotrophic lateral sclerosis, will serve him well in his new role. I would also like to take this opportunity to thank Dr. Roderick McInnes for his service to Canadians and the health research community during his tenure as Acting President of CIHR.”
The Honourable Ginette Petitpas Taylor
As Dr. Michael Strong mentioned at the end of May, he will not be seeking a second term as President of CIHR. His last day in the role will be July 7, 2023, after which he will return to Western University to continue overseeing his research program focused on ALS, or Lou Gehrig's disease.
As President, I will always seek to strengthen CIHR’s ability to support innovative health research and to collaborate with like-minded organizations – both in Canada and around the world. In these and all other matters, our decisions will be principled, driven by our legislative mandate, and guided by our duty to be responsible stewards of ...
I also want to take this opportunity to thank all of you who have given so graciously of your time to assist us over the past year in developing a new strategic plan that lives up to the enduring goals of those who founded CIHR. This year will be the 20th anniversary of the founding of CIHR.
Michael J. Strong, MD, FRCPC, FAAN, FCAHS President, CIHR. The Canadian Institutes of Health Research. As Canada's health research investment agency, CIHR collaborates with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health systems.
People also ask
Who is CIHR President?
What is Dr Strong's research focusing on?
How will CIHR achieve the best health for all?
When did Dr Strong's term end?
Jun 20, 2018 · "I am pleased to announce the appointment of Dr. Michael Strong as the new President of CIHR. Dr. Strong's distinguished track record as a biomedical researcher, professor, and...
